Clinical Studies on the Mechanism of Introduction of Milk Allergy by Slowly Increasing Oral Immunotherapy

Clinical Studies on the Mechanism of Introduction of Milk Allergy by Slowly Increasing Oral Immunotherapy - Clinical Studies on the Mechanism of Introduction of Milk Allergy by Slowly Increasing Oral Immunotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033157

Enrollment

Registered

2018-06-28

Start date

2018-06-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

milk allergy

Interventions

intake of milk everyday Removal of milk intake

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with milk allergy

Exclusion criteria

Exclusion criteria: (1)patients with beta inhibitors (2)pregnant (3) patients with unstable severe asthma (less than 70% per second) (4) systemically serious diseases (malignant tumors,autoimmune diseases, immunodeficiency diseases, severe heart diseases, chronic infections, etc.)(5) continuous use of corticosteroid or anticancer drug(6)acute infection

Design outcomes

Primary

Measure	Time frame
The count of antigen-specific T cells in 1 year after the start of oral immunotherapy	—

Countries

Japan

Contacts

Public ContactYasuto Kondo

Banbuntane Hotokukai Hospital pediatrics

ykondo@fujita-hu.ac.jp052-323-5649

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026